All | Number of ICU admissions | Model estimates | ||||
2017–2019 (n, %) | 2020 (n, %) | Unadjusted (OR, 95% CI) | P value | Adjusted* (OR, 95% CI) | P value | |
108/1287 (8.4) | 48/380 (12.6) | 1.53 (1.07–2.18) | 0.02* | 1.73 (1.18–2.53) | 0.005* | |
Tumour type | ||||||
CNS tumour | 72/405 (17.8) | 30/103 (29.1) | 1.9 (1.16 to 3.12) | 0.01* | 2.12 (1.28 to 3.51) | 0.004* |
Lymphoma | 14/300 (4.7) | 3/96 (3.0) | 0.6 (0.18 to 2.27) | 0.5 | 0.6 (0.18 to 2.26) | 0.5 |
Leukaemia | 15/295 (5.1) | 12/112 (10.7) | 2.2 (1.01 to 4.95) | 0.04* | 2.4 (1.02 to 5.75) | 0.04* |
Sarcoma | 3/232 (1.3) | 3/51 (5.9) | 4.8 (0.93 to 24.4) | 0.06 | 3.2 (0.68 to 15.6) | 0.1 |
Age category | ||||||
0–15 years | 64/654 (9.8) | 35/205 (17.1) | 1.90 (1.23 to 2.93) | 0.004* | 2.2 (1.33 to 3.47) | 0.002* |
16–24 years | 44/633 (7.0) | 13/175 (7.4) | 0.98 (0.52 to 1.85) | 0.9 | 1.1 (0.54 to 2.2) | 0.8 |
Surgical cases excluded | ||||||
All | 60/1239 (4.8) | 25/357 (7.0) | 1.47 (0.91 to 2.40) | 0.1 | 1.62 (0.97 to 2.71) | 0.04* |
0–15 years | 43/633 (6.8) | 23/193 (11.9) | 1.85 (1.09 to 3.17) | 0.02* | 2.0 (1.15 to 3.55) | 0.01* |
16–24 years | 17/606 (2.8) | 2/164 (1.2) | 0.43 (0.1 to 1.87) | 0.3 | 0.47 (0.1 to 2.16) | 0.3 |
*Adjusted for age, sex, deprivation level and tumour type for all cancers; adjusted for age, sex, deprivation level for tumour subtypes; adjusted for sex, deprivation level and tumour type for different age categories.
CNS, central nervous system; CTYA, childhood, teenage and young adult; ICU, intensive care unit.